Contaminants found in Merck products including Gardasil
July 29, Merck announced a problem with charred bits of plastic shrink wrap contaminating vials of vaccines manufactured at its plant in West Point, Pa. The tainted products include Gardasil, marketed as a vaccine against the human papillomavirus (HPV), a sexually transmitted virus linked to the development of cervical cancer.

There is much debate about the vaccine Gardasil, which was introduced in 2006 for girls, and marketed as a weapon against cervical cancer. The vaccine actually targets human papillomavirus (HPV), a sexually transmitted virus that is linked to the development of cervical cancer. While originally targeted only at girls and young women, the FDA recently expanded approval of the drug for use in boys and young men, to prevent the spread of HPV.
S.A.N.E. Vax, Inc., a non-profit organization established to promote safe, affordable, necessary, effective vaccines and vaccination practices, has announced a combined effort of concerned citizens worldwide to insist on government compliance with regulations and guidelines in the implementation and monitoring of vaccines. In particular, the outreach effort is focusing on Gardasil, manfuactured by Merck and marketed as a preventive for cervical cancer by targeting the human papillomavirus (HPV). According to a recent news release, SaneVax is encouraging an open letter writing campaign addressing the issue of vaccine safety.
A writer on the blog site
Two years after HPV-vaccine Gardasil was introduced to the public in 2006, CNN examined reports of serious adverse